181 related articles for article (PubMed ID: 2918846)
1. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
Weisweiler P
Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
Weisweiler P; Merk W; Jacob B; Schwandt P
Eur J Clin Pharmacol; 1986; 30(2):191-4. PubMed ID: 3709644
[TBL] [Abstract][Full Text] [Related]
3. Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol.
Desager JP; Horsmans Y; Harvengt C
J Clin Pharmacol; 1991 Jun; 31(6):537-42. PubMed ID: 1880219
[TBL] [Abstract][Full Text] [Related]
4. Colestipol plus fenofibrate versus synvinolin in familial hypercholesterolaemia.
Weisweiler P; Schwandt P
Lancet; 1986 Nov; 2(8517):1212-3. PubMed ID: 2877340
[No Abstract] [Full Text] [Related]
5. Plasma lipid concentrations and lecithin:cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.
Heller FR; Desager JP; Harvengt C
Metabolism; 1981 Jan; 30(1):67-71. PubMed ID: 7464555
[TBL] [Abstract][Full Text] [Related]
6. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
Kłosiewicz-Latoszek L; Nowicka G; Szostak WB; Naruszewicz M
Atherosclerosis; 1987 Feb; 63(2-3):203-9. PubMed ID: 3827981
[TBL] [Abstract][Full Text] [Related]
7. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Vega GL; East C; Grundy SM
Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427
[TBL] [Abstract][Full Text] [Related]
9. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
Malloy MJ; Kane JP; Kunitake ST; Tun P
Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
[TBL] [Abstract][Full Text] [Related]
10. Serum lipoproteins and lecithin: cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given beta-sitosterol.
Weisweiler P; Heinemann V; Schwandt P
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):204-6. PubMed ID: 6715090
[TBL] [Abstract][Full Text] [Related]
11. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
12. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
13. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
[TBL] [Abstract][Full Text] [Related]
14. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
Illingworth DR
Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
[TBL] [Abstract][Full Text] [Related]
15. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP
Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081
[TBL] [Abstract][Full Text] [Related]
16. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
17. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
18. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
19. Probucol with colestipol in the treatment of hypercholesterolemia.
Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of niacin, colestipol, and fat-controlled diet in men with coronary bypass. Effect on blood lipids and apolipoproteins.
Nessim SA; Chin HP; Alaupovic P; Blankenhorn DH
Arteriosclerosis; 1983; 3(6):568-73. PubMed ID: 6651612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]